Our Pricing

Is Orlistat as Good as Mounjaro for Weight Loss?

Published: 11 September 2026

Is orlistat as good as mounjaro? This is one of the most common questions we receive from patients exploring weight loss treatments at Cured Pharmacy. While both medications are licensed for weight management in the UK, they work through entirely different mechanisms and deliver markedly different results in clinical trials. Understanding these differences is essential for choosing the right treatment under the guidance of a UK prescriber.

Is Orlistat as Good as Mounjaro: Mechanism of Action Compared

When asking is orlistat as good as mounjaro, the first critical difference lies in how each medication works. Orlistat is a lipase inhibitor that blocks approximately 30% of dietary fat absorption in the gastrointestinal tract [1]. It works locally in the gut and is not systemically absorbed, preventing the breakdown of fats into absorbable molecules. This mechanism requires adherence to a reduced-calorie, lower-fat diet to minimise gastrointestinal side effects.

Mounjaro (tirzepatide), by contrast, is a dual GIP/GLP-1 receptor agonist administered via weekly subcutaneous injection [2]. It works systemically by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways. This multi-targeted approach addresses both metabolic and behavioural aspects of weight regulation, leading to substantially greater weight loss in clinical trials compared to fat absorption inhibitors like orlistat.

Clinical Trial Evidence: Is Orlistat as Good as Mounjaro for Weight Loss?

The clinical evidence clearly demonstrates that is orlistat as good as mounjaro is answered with a definitive no when comparing average weight loss outcomes. In the XENDOS trial, orlistat 120mg three times daily combined with lifestyle modification resulted in an average weight loss of 5.8kg over four years, representing approximately 5-10% of baseline body weight [1]. While this is clinically meaningful, it requires strict dietary adherence and consistent dosing with every main meal.

The SURMOUNT-1 trial for tirzepatide (the active ingredient in Mounjaro) showed dramatically superior results. Participants receiving the 15mg maintenance dose achieved an average weight reduction of 20.9% of baseline body weight over 72 weeks—more than triple the weight loss seen with orlistat [2]. Even the lowest tirzepatide dose (5mg) produced average weight loss of 15%, still substantially exceeding orlistat's outcomes. These head-to-head comparisons from robust randomised controlled trials provide clear guidance for UK prescribers and patients.

Real-World Weight Loss Expectations

In our clinical experience at Cured Pharmacy, patients frequently ask is orlistat as good as mounjaro when considering real-world results beyond trial data. Orlistat typically produces modest but sustainable weight loss when combined with a structured dietary programme, with most patients losing 5-10% of body weight over six months [3]. However, adherence can be challenging due to gastrointestinal side effects if dietary fat intake is not carefully controlled.

Mounjaro patients in our practice commonly report 15-25% total body weight reduction over 12-18 months, with appetite suppression being the most frequently cited benefit [4]. The once-weekly injection schedule and systemic appetite control make adherence significantly easier for many patients compared to thrice-daily oral capsules that require careful meal timing and fat restriction.

Side Effect Profile: Is Orlistat as Good as Mounjaro for Tolerability?

When considering is orlistat as good as mounjaro from a tolerability perspective, the side effect profiles differ substantially. Orlistat's most common adverse effects are gastrointestinal: oily stools, faecal urgency, flatulence with discharge, and oily spotting [1]. These effects are directly related to unabsorbed fat passing through the digestive system and can be socially distressing. They are dose-dependent and worsen with higher dietary fat intake, which serves as an aversive behavioural reinforcement for dietary adherence.

Mounjaro's side effects are primarily gastrointestinal as well but of a different nature: nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation [2]. These typically diminish over 4-8 weeks as the body adapts. Rare but serious risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours (seen in rodent studies, not confirmed in humans). Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [4].

Cost Comparison UK: Is Orlistat as Good as Mounjaro Value?

From a cost perspective, is orlistat as good as mounjaro depends on how you define value. Orlistat is significantly cheaper, starting from £124.99 per month at Cured Pharmacy for generic 120mg capsules. Branded Xenical costs from £124.99, and lower-dose Alli (60mg) or Orlos are available from £124.99 for over-the-counter purchase. This makes orlistat the most accessible weight loss medication in the UK market.

Mounjaro costs from £124.99 per month at Cured Pharmacy, representing a substantially higher investment. However, when cost is evaluated per kilogram of weight lost based on clinical trial data, Mounjaro may offer superior cost-effectiveness for patients who achieve the average 15-25% body weight reduction. Additionally, Cured Pharmacy offers £20 off your first order with code Weightlossnew, making initial treatment more accessible. All prescription treatments require completion of a free online clinical assessment by our UK-registered prescribers.

NHS vs Private Prescription Access

Understanding is orlistat as good as mounjaro also requires considering NHS availability. Orlistat can be prescribed on the NHS for patients with BMI ≥30 kg/m² (or ≥28 kg/m² with comorbidities) and is also available over-the-counter at 60mg strength [3]. This makes it widely accessible through multiple pathways.

Mounjaro is currently not routinely available on NHS prescription for weight management, though NICE guidance is under review. Most UK patients access tirzepatide through private prescription services like Cured Pharmacy, where our transparent upfront pricing (£124.99 per month) and UK-registered clinical team provide a safe, regulated pathway to treatment.

Who Should Choose Orlistat vs Mounjaro: Is Orlistat as Good as Mounjaro for You?

The question is orlistat as good as mounjaro ultimately depends on individual patient factors. Orlistat may be the appropriate first-line choice for patients with BMI 28-35 kg/m² who prefer oral medication, have budget constraints, are committed to structured dietary modification, and do not have contraindications to fat malabsorption (such as chronic malabsorption syndrome or cholestasis) [1]. It's particularly suitable for patients who want to avoid injectable medications or who have contraindications to GLP-1 receptor agonists.

Mounjaro is typically more appropriate for patients with BMI ≥30 kg/m² (or ≥27 kg/m² with weight-related comorbidities like type 2 diabetes), those who have not achieved adequate weight loss with orlistat or lifestyle modification alone, patients who struggle with appetite control, and those willing to self-administer weekly subcutaneous injections [2]. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team conduct thorough assessments to determine suitability, contraindications, and monitoring requirements for each patient.

Final Verdict: Is Orlistat as Good as Mounjaro for UK Patients?

After reviewing mechanism, efficacy, safety, and cost, is orlistat as good as mounjaro? The evidence-based answer is that Mounjaro (tirzepatide) delivers significantly greater weight loss—typically 15-25% of body weight compared to orlistat's 5-10%—through a more comprehensive metabolic and appetite-regulating mechanism [2][4]. However, orlistat remains a valuable, more affordable option for patients with lower BMI, those preferring oral medication, or as an initial step in a staged treatment approach.

At Cured Pharmacy, we provide both treatments with full clinical oversight, transparent pricing from £124.99 for orlistat and £124.99 for Mounjaro, and free online consultations completed in under three minutes. Our UK-registered prescribers assess your medical history, current medications, weight loss goals, and individual risk factors to recommend the most appropriate treatment. All medicines are genuine UK-licensed products dispensed from our GPhC-registered pharmacy (9012511) with 100% discreet packaging and next-day delivery available.

Starting Your Weight Loss Journey at Cured Pharmacy

Whether you choose orlistat or Mounjaro, the most important step is beginning under proper medical supervision. Cured Pharmacy's clinical pathway includes baseline assessment, ongoing monitoring, dose titration guidance for Mounjaro, and access to our pharmacist-led support team throughout your treatment journey. Use code Weightlossnew for £20 off your first order, and start your confidential online assessment today to determine which treatment is right for you.

Scientific References

1. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. [accessed 11 September 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
3. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (CG189). NICE. [accessed 11 September 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 11 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.